The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027.
The global prefilled syringes market size achieved a valuation of US$ 7,742.9 million in 2022. It is expected to experience remarkable growth, reaching an estimated value of US$ 20,167.8 million by 2032. This growth trajectory reflects a robust projected compound annual growth rate (CAGR) of 10.0% from 2022 to 2032.
The global prefilled syringes market is estimated to garner a revenue of about USD 16100 Million by the end of 2033 by growing at a CAGR of ~12% over the forecast period, i.e., 2023 – 2033.
This research study includes an extensive analysis of the prefilled syringes market, by product type, material, design and geographical regions, allowing the researcher to develop a comprehensive outlook of the market. The two major segments described in the study are glass-based and plastic-based prefilled syringes. Each of these segments has been analyzed on the basis of their current and future market size and market volume, considering the macro and micro environmental factors.
Surge in home-based healthcare activities, adoption of injectable drugs, increase in incidence of chronic diseases, and benefits of prefilled syringes over conventional vial drive the growth of the global prefilled syringes market.
Increasing demand for easy-to-use drug delivery devices and technological advancements in injectable drug delivery devices are key factors driving global market revenue growth
The global prefilled syringes market attained a value of $1,914.1 million in 2020, and it is predicted to progress at a CAGR of 6.8% between 2021 and 2030. Furthermore, the market is predicted to reach a revenue of $3,646.7 million by 2030. The factors fueling the expansion of the market are the surging concerns raised over the prevalence of needlestick injuries, various advantages of prefilled syringes over conventional vial and syringe packaging systems, and the burgeoning requirement for point-of-care administration.
The global sales of prefilled syringes market amounted to US$3.5 bn in 2015 and prefilled syringes market is projected to reach US$7.9 bn, expanding at a CAGR of 9.3% over the period of 2016 to 2024. Prefilled syringes market segments of the injectable drug delivery devices market.
Persistence Market Research (PMR), in its new offering, opines global double chamber prefilled syringes market to grow at a CAGR of 9% during the forecast period.
Big Market Research presents Global Prefilled Syringes Market. The analysis provides an overview of the factors driving and limiting the growth of the market, including market trends, market structure and others.The analysis assists in understanding the strategies adopted by the companies for the growth of this market.In-depth analysis of the types of products used in the prefilled syringes market would help in identifying the future applications in this market. Read The Complete Report On : http://www.bigmarketresearch.com/prefilled-syringes-market
Some of the top companies operating in the GCC syringes and needles market are – Becton, Dickinson & Company, Nipro Corporation, Baxter International Inc., B. Braun, Terumo Corporation, Medtronic PLC., Smiths Group Inc., Abu Dhabi Medical Devices Company, SAAPP (FZC) LLC., and IBN Sina Medical Factory.
According to PMR, the global double chamber prefilled syringes market is estimated to have accounted for approximately US$ 1.4 Bn in terms of value in 2018. High convenience associated with the usage of double chamber prefilled syringes is driving their adoption among end users, which is boosting the demand for double chamber prefilled syringes. This is one of the leading factors that are significantly contributing to the growth of the double chamber prefilled syringes market. Moreover, double chamber prefilled syringes facilitate next-generation drug delivery technology and are more patient-centric as compared to traditional modes..
Persistence Market Research (PMR), in its new offering, opines global double chamber prefilled syringes market to grow at a CAGR of 9% during the forecast period.
The report on Pre Filled Syringes Market by product type (glass, plastic pre filled syringes), therapeutic category (insulin, vaccine, arthritis, heparin, pcsk9 inhibitor pre filled syringes), design (single, dual-chamber, customized prefilled syringes) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Pre Filled Syringes Market is projected to grow at a CAGR of 9.10% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
According to the latest research report by IMARC Group, The global disposable syringes market size reached US$ 15.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032. More Info:- https://www.imarcgroup.com/disposable-syringes-market
Global lyophilized injectable drugs market size is expected to reach $4.48 Bn by 2028 at a rate of 3.3%, segmented as by packaging type, specialty packaging, point-of-care reconstitution, single-use vials, other packaging types.
The asthma drugs market is projected to reach US$ 34,136.10 million in 2028 from US$ 24,239.17 million in 2021; it is estimated to grow at a CAGR of 5.0 % during 2021–2028.
The subcutaneous drug delivery devices market was valued at US$ 9,243.80 million in 2018 and it is projected to reach US$ 17,290.47 million in 2027; it is expected to grow at a CAGR of 7.4% from 2019 to 2027.
The global emulsifiers market size is expected to reach USD 13.08 Billion at a revenue CAGR of 6.3% in 2028, according to latest analysis by Emergen Research. Rapidly rising demand for convenience and processed foods, increasing oil and gas exploration and production activities, and increasing food demand globally are some key factors driving steady market revenue growth.
European Drug Delivery Technologies and Nasal sprays Market report categorizes the European Market by Technologies (Auto Injectors, Transdermal Patches , Injectable, Ocular, Transdermal , Oral, Pulmonary, Nasal, Topical, Implantable, and Transmucosal Drug Delivery) & by Geography.
Big Market Research, Global Safety Syrings Market Size, Share, Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast 2013-2020. The competitive structure of the global safety syringes market and would be helpful for strategic industry analysis.Safety syringes consist of an inbuilt safety mechanism and either a detachable or permanently attached needle.
The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020.
The European injectable drug delivery technologies market was valued at $6.8 billion in 2012; it is expected to reach $12.4 billion by 2017 at a CAGR of 12.7% from 2012 to 2017.
Drug-device combination market is analysed by Data Bridge Market Research, wherein we have accounted for the market to witness a potential growth rate of 7.43% in the forecasted period of 2020 to 2027, resulting in the market reaching a cap of USD 198.57 billion by the end of the forecasted period. Increasing growth witnessed across the chronic disease prevalence which have been caused due to the rising volume of geriatric population, these trends are acting as the major driving factors for the drug-device combination market in the above-mentioned forecasted period of 2020 to 2027.
The Global Injectable Drug Delivery Market accounted for $26.8 billion in 2014 and is expected tgrow at a CAGR of 13.9% treach $76.1 billion by 2022. The factors driving the injectable drug delivery market include rising incidences of chronic diseases, technological advancements and increase in demand for self injection devices. Chronic disease rates are increasing at 14% each year. In 2012, 63% of the deaths across the world were due tchronic diseases.
Market for prefilled syringes has been witnessing growth majorly due to the advancement in technology for self-administration of drugs for diseases such as deep vein thrombosis and autoimmune diseases.https://www.bharatbook.com/medical-devices-market-research-reports-166810/global-prefilled-syringes.html
In one of the statistics by the World Health Organization (WHO), the prevalence of diabetes, a chronic disease, in the year 2019, was known to be the 9th leading cause of death globally. Further, in that very same year, around 1.5 Million people were known to die due to the disease.
The global autoinjector market is predicted to grow at 16.9% CAGR during the forecast period with the market size reaching USD 4.5 billion by 2024. The market is driven by the factorssuch as high prevalence of chronic and lifestyle associated diseases, increasing number of regulatory approvals, technology anddesign improvement, escalating patient attentiveness and inclination of patients regarding self-administration. The prefilled autoinjectors are the major contributor to the global market., as more patients preferred disposable injectors due to ease of their usage and lower chances of any contamination.
The growing prevalence of anaphylaxis and surging aging population are two of the key factors responsible for the growth of the auto-injectors market. The market is predicted to advance at a CAGR of 18.6% during the forecast period (2017–2023). An auto-injector is a medical device used for injecting a particular dose of drugs in patients. Most of the auto-injectors are spring-loaded syringes, designed for the safe dispensation of drugs with ease. Based on product, the auto-injectors market is bifurcated into prefilled and fillable injectors.
The market research analysts estimate the vaccines packaging segment to account for more than 58% of the total market share by the end of 2020. The ability of prefilled vaccine syringes to meet the needs to healthcare facilities, such as reducing wastage, decreasing the time for drug administration, and reducing the risks of errors and contamination, will foster its adoption for vaccination purposes during the forecast period. Buy a copy of report @ http://www.reportsnreports.com/Purchase.aspx?name=446039 Single User License: US $ 2500;
Download Free Research Report PDF @ http://bit.ly/2NOJWkL #SmallVolumeParenteral #MarketAnalysis Small Volume Parenteral (SVP) solutions are usually 100 ml or less and are packaged in different ways depending on the intended use. If the SVP is a liquid that is used primarily to deliver medications, it is packaged in a small plastic bag called a minibag of 50 - 100 ml (minibags look like small plastic LVP bags). Small Volume Parenteral (SVP)s can also be packaged as ampules, vials, and prefilled syringes. Liquid drugs are supplied in prefilled syringes, heat-sealed ampules, or in vials sealed with a rubber closure. Powdered drugs are supplied in vials and must be constituted (dissolved in a suitable liquid) before being added to any solution. Full Report Url - http://bit.ly/2QnASoG
The autoinjector is a small device which helps to deliver a fixed dose of a particular drug. These are typically spring-loaded syringes, which are specifically designed for the drug's convenience and secure dispensation. The market for Auto-injectors has grown significantly in the last few years; this growth is due to the rising incidence of lifestyle-related and chronic diseases, the growth in the number of anaphylaxis, and the development of technology. According to Renub Research analysis, Global Auto-Injector Market is forecasted to be US$ 5.8 Billion by the end of the year 2026.
Improved convenience, affordability, sterility, safety, and accuracy delivered by prefilled syringes over traditional syringes are the key parameters fueling the widespread adoption of the prefilled syringes around the world. The parenteral drug delivery has enjoyed a dominating demand over last century owing to wide adoption, however, lack of convenience, affordability, and safety concerns have reduced the preference for traditional syringe and veil based drug delivery.
The Global Special Purpose Needles Market was valued at US$ 10.44 billion in 2021 and is predictable to reach US$ 22.01 billion by 2030 which is projected to attain a CAGR of 8.6 % during the forecast period from 2021- 2030. Needles are referred as a device made up of metal, glass, or rubber tubes used for delivering drugs and collecting fluids from the body.
According to The Insight Partners market research study titled Subcutaneous Drug Delivery Devices Market - Global Analysis and Forecasts by Technology, Syringe Type, Distribution Channel and Geography. The global subcutaneous drug delivery devices market is expected to reach US$ 17,290.47 Mn in 2027 from US$ 9,243.80 in 2018. The market is estimated to grow with a CAGR of 7.4% from 2019-2027. The report highlights the trends prevalent in the global subcutaneous drug delivery devices market and the factors driving the market along with those that act as deterrents to its growth.
The global autoinjector market is primarily driven by the increasing incidences of chronic and lifestyle diseases and the escalating demand for enhanced patient convenience. Additionally, individuals are rapidly shifting from conventional devices toward self-administrating devices, such as autoinjectors, due to the growing awareness regarding their benefits For an Executive Summary of Autoinjector Report Visit the following link: https://www.imarcgroup.com/autoinjector-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
The Pharmaceutical Packaging Market is estimated to reach US$186.8 billion by 2028, growing at a CAGR of 9.4% over the forecast period 2023-2028. The market growth is projected to be driven by pharmaceutical packaging solution providers' increased attention to sustainability and their use of recyclable and biodegradable materials. From February 2019, under the Commission Delegated Regulation (EU) 2016/161, pharmaceutical makers are required to add a unique identifier and an anti-tampering device to the packaging of most centrally authorized pharmaceutical products.
Global Pharmaceutical Packaging Market Research Report: Information by Material (Plastic, Paper & Paperboard, Glass), Type (Bottle, Aerosol Pack, Tubes, Blister Pack, Sachets), Packaging (Rigid, Flexible, Semi-rigid), Application (Generic Drugs, Branded Drugs, Medical Tools & Equipment, Test Kits, Nutraceuticals), and Region - Forecast till 2023
Insulin Pens is a medication used along with emergency medical treatment services for the allergic reactions caused by insect bites or stings, foods, drugs, and latex, among others. It works by relaxing the muscles in the airways and tightening the blood vessels. The injection is available as a prefilled automatic injection device that contains the solution and in vials to inject subcutaneously and others.
Lyophilized Injectable Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type of Packaging, Type of Delivery, Indication, and End User,” the market is expected to grow from US$ 2,719.42 million in 2021 to US$ 4,001.27 million by 2028; it is expected to grow at a CAGR of 5.8% from 2022 to 2028.
According to the latest research report by IMARC Group, The India generic injectables market size reached US$ 2.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.9 Billion by 2028, exhibiting a growth rate (CAGR) of 12.4% during 2023-2028. More Info:- https://www.imarcgroup.com/india-generic-injectables-market
Big Market Research “Sterile Medical Packaging Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/sterile-medical-packaging-in-the-us-2015-2019-market Medical products include pharmaceutical products, medical devices, surgical devices, and other healthcare-related products. Drugs/pharma products hold a major share in the Sterile Medical market. The packaging of medical products is a complex process because of their molecular and chemical structures. They need to be packaged with extremely protective and durable materials to prevent contamination.
The global home healthcare market size was USD 198.78 Billion in 2021 and is expected to register a revenue CAGR of 8.3%, during the forecast period, according to the latest analysis by Emergen Research. Home healthcare market revenue growth is primarily driven by factors such as rising incidence of chronic diseases such as diabetes, cardiovascular disease, and hypertension and increasing technological advancements in-home healthcare products.
The global fill finish manufacturing market is estimated to garner a revenue of USD 15828.8 Million by the end of 2031 by growing at a CAGR of 10.70% over the forecast period, i.e., 2022 – 2031.
The global optically clear adhesives market size is expected to reach USD 3,218.7 Million in 2028 and register a revenue CAGR of 9.2% over the forecast period, according to latest analysis by Emergen Research. Some key factors driving steady market revenue growth include rising demand for touchscreen display devices and optical devices among consumers.
Lyophilized Injectable Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type of Packaging, Type of Delivery, Indication, and End User,” the market is expected to grow from US$ 2,719.42 million in 2021 to US$ 4,001.27 million by 2028
Disposable medical supplies represent the largest segment within the global healthcare equipment and supplies sector. For More Details: http://goo.gl/PtXuV9
The global endometrial ablation devices market size is expected to reach USD 1,596.9 Million at a steady revenue CAGR of 5.3% in 2028, according to latest analysis by Emergen Research. Steady endometrial ablation devices market revenue growth can be attributed to rising prevalence of gynecological disorders in women, including menorrhagia that are responsible for patients opting for advanced surgical procedures such as endometrial ablation.
Big Market Research has announced a new Report Package "Global Pharmaceutical Packaging Market-Size, Share, Trends, Forecast,Development, Situation, Future outlook, Potential" Get Complete Details At: http://www.bigmarketresearch.com/global-pharmaceutical-packaging-2014-2018-market A pharmaceutical product is any chemical substance formulated or compounded as a single active ingredient. The packaging of medicines is a very complex process, and because of its molecular and chemical structure, it needs to be packed in an extremely durable material so that it could reach the customer in a desirable condition. Enquire About This Report at: http://www.bigmarketresearch.com/report-enquiry/150151